Comparing biomarkers for COVID-19 disease with commonly associated preexisting conditions and complications
View ORCID ProfileJesse Huang
doi: https://doi.org/10.1101/2020.10.02.20205609
Jesse Huang
1Kii Research Institute, Vancouver, Washington, USA
2Center of Molecular Medicine, Department of Clinical Neuroscience, Karolinska University Hospital, Karolinska Institutet, SE-171 77 Stockholm, Sweden

Data Availability
Study data is available for request as of October 2, 2020.
Posted October 05, 2020.
Comparing biomarkers for COVID-19 disease with commonly associated preexisting conditions and complications
Jesse Huang
medRxiv 2020.10.02.20205609; doi: https://doi.org/10.1101/2020.10.02.20205609
Subject Area
Subject Areas
- Addiction Medicine (214)
- Allergy and Immunology (495)
- Anesthesia (106)
- Cardiovascular Medicine (1091)
- Dermatology (141)
- Emergency Medicine (274)
- Epidemiology (9747)
- Gastroenterology (480)
- Genetic and Genomic Medicine (2299)
- Geriatric Medicine (221)
- Health Economics (461)
- Health Informatics (1548)
- Health Policy (729)
- Hematology (236)
- HIV/AIDS (500)
- Medical Education (236)
- Medical Ethics (67)
- Nephrology (256)
- Neurology (2137)
- Nursing (133)
- Nutrition (332)
- Oncology (1171)
- Ophthalmology (363)
- Orthopedics (128)
- Otolaryngology (220)
- Pain Medicine (145)
- Palliative Medicine (50)
- Pathology (308)
- Pediatrics (693)
- Primary Care Research (265)
- Public and Global Health (4640)
- Radiology and Imaging (775)
- Respiratory Medicine (622)
- Rheumatology (273)
- Sports Medicine (208)
- Surgery (250)
- Toxicology (42)
- Transplantation (120)
- Urology (94)